KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Non-Current Assets (2017 - 2025)

Moderna (MRNA) has disclosed Non-Current Assets for 9 consecutive years, with $5.8 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 4.12% to $5.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.1 billion through Dec 2025, down 8.77% year-over-year, with the annual reading at $5.8 billion for FY2025, 4.12% down from the prior year.
  • Non-Current Assets for Q4 2025 was $5.8 billion at Moderna, up from $5.5 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $12.5 billion in Q2 2022, with the low at $991.0 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $7.9 billion, with a median of $7.3 billion recorded in 2021.
  • The sharpest move saw Non-Current Assets skyrocketed 1036.13% in 2022, then tumbled 46.66% in 2024.
  • Over 5 years, Non-Current Assets stood at $8.6 billion in 2021, then soared by 44.53% to $12.4 billion in 2022, then plummeted by 34.81% to $8.1 billion in 2023, then fell by 25.4% to $6.0 billion in 2024, then decreased by 4.12% to $5.8 billion in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $5.8 billion, $5.5 billion, and $5.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.